Drug information
Audio
| cabotegravir and rilpivirine.mp3 |
Pronounce:
Brand Name
Cabenuva
Other Names
CAB and RPV, CAB plus RPV, Cabenuva kit, cabotegravir extended-release injectable suspension and rilpivirine extended-release injectable suspension
Drug Class
Combination Drugs
Integrase Strand Transfer Inhibitor (cabotegravir)
Non-Nucleoside Reverse Transcriptase Inhibitor (rilpivirine)
Drug Image(s): (Click to enlarge)
Chemical Image: (Click to enlarge)
cabotegravir
Molecular Weight: 405.3553
rilpivirine
Molecular Weight: 366.4262
(The drug image[s] shown above are of brand products only. There may be other available products not shown.)
FDA label informationFDA label information
Several FDA-approved drug labels may be available for cabotegravir / rilpivirine. Clinicalinfo provides the following link to the DailyMed drug label solely as an example of the labels available for cabotegravir / rilpivirine. Inclusion or absence of a drug label link on the Clinicalinfo site does not imply endorsement or lack thereof by Clinicalinfo. Search DailyMed or Drugs@FDA to access more information on cabotegravir / rilpivirine, including additional drug labels and any generic equivalents.
Kit (injection)